Contact
Please use this form to send email to PR contact of this press release:
GSK announces top-line results from pivotal Phase III study of darapladib in chronic coronary heart disease
TO:
Please use this form to send email to PR contact of this press release:
GSK announces top-line results from pivotal Phase III study of darapladib in chronic coronary heart disease
TO: